Indaptus Therapeutics Inc (NASDAQ:INDP) shares, rose in value on Friday, June 20, with the stock price down by -17.90% to the previous day’s close as strong demand from buyers drove the stock to $0.27.
Actively observing the price movement in the last trading, the stock closed the session at $0.33, falling within a range of $0.2701 and $0.3399. The value of beta (5-year monthly) was 1.123. Referring to stock’s 52-week performance, its high was $2.54, and the low was $0.30. On the whole, INDP has fluctuated by -31.65% over the past month.
With the market capitalization of Indaptus Therapeutics Inc currently standing at about $4.33 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that INDP’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of INDP currently trading nearly -20.06% and -33.59% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 31.15, while the 7-day volatility ratio is showing 10.56% which for the 30-day chart, stands at 8.65%. Furthermore, Indaptus Therapeutics Inc (INDP)’s beta value is 1.55, and its average true range (ATR) is 0.04.
A comparison of Indaptus Therapeutics Inc (INDP) with its peers suggests the former has fared considerably weaker in the market. INDP showed an intraday change of -17.90% in last session, and over the past year, it shrunk by -89.77%%.
Data on historical trading for Indaptus Therapeutics Inc (NASDAQ:INDP) indicates that the trading volumes over the past 10 days have averaged 0.57 and over the past 3 months, they’ve averaged 435.05K. According to company’s latest data on outstanding shares, there are 16.03 million shares outstanding.
Nearly 19.56% of Indaptus Therapeutics Inc’s shares belong to company insiders and institutional investors own 13.08% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.02 million shares as on 2025-05-30, resulting in a short ratio of 1.56. According to the data, the short interest in Indaptus Therapeutics Inc (INDP) stood at 903.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.12 million. The stock has fallen by -67.93% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the INDP stock heading into the next quarter.
